Research ArticleBIOCHEMISTRY

Peripheral myelin protein 22 alters membrane architecture

+ See all authors and affiliations

Science Advances  05 Jul 2017:
Vol. 3, no. 7, e1700220
DOI: 10.1126/sciadv.1700220

You are currently viewing the abstract.

View Full Text


Peripheral myelin protein 22 (PMP22) is highly expressed in myelinating Schwann cells of the peripheral nervous system. PMP22 genetic alterations cause the most common forms of Charcot-Marie-Tooth disease (CMTD), which is characterized by severe dysmyelination in the peripheral nerves. However, the functions of PMP22 in Schwann cell membranes remain unclear. We demonstrate that reconstitution of purified PMP22 into lipid vesicles results in the formation of compressed and cylindrically wrapped protein-lipid vesicles that share common organizational traits with compact myelin of peripheral nerves in vivo. The formation of these myelin-like assemblies depends on the lipid-to-PMP22 ratio, as well as on the PMP22 extracellular loops. Formation of the myelin-like assemblies is disrupted by a CMTD-causing mutation. This study provides both a biochemical assay for PMP22 function and evidence that PMP22 directly contributes to membrane organization in compact myelin.

  • Charcot-Marie-Tooth Disease
  • Electron Microscopy
  • Membrane
  • Myelin
  • Neuropathy
  • Peripheral Myelin Protein 22
  • Peripheral Nervous System
  • PNS
  • Reconstitution

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

View Full Text